### Consensus provenance reconciliation — 9 October 2026

Case-specific Consensus discovery records were located and linked to this final edition. This supplements the review's provenance; it leaves the original assessed claim, grades and source counts intact. Provider summaries and full-text badges do not establish examination of original primary passages by this reviewer. Source access and incorporation retain the limits stated in the original methods and any dated research update.

Recorded evidence artifacts:

- `deliverables/prepublication-enrichment-2026-10-05/website-series/hpv-cervical-carcinoma/consensus-browser-links.json`
- `deliverables/prepublication-enrichment-2026-10-05/website-series/hpv-cervical-carcinoma/consensus-browser.txt`
- `deliverables/prepublication-enrichment-2026-10-05/website-series/hpv-cervical-carcinoma/consensus-targeted-check.txt`

The located artifacts do not state a reliable source-comparison count. No count is inferred.

**Existing source reconciliation:** Yes; 9 primary identifiers matched; update says abstract/metadata checked and notes broad response irrelevance plus focused follow-up retrieval gaps. No independently readable body for Consensus-reported full-text details; initial broad response had irrelevant records.

Matched primary identifiers in the preserved dated ledger: PMID 10451482, PMID 17494925, PMID 19435895, PMID 21900119, PMID 25100830, PMID 32997908, PMID 34741816, PMID 37702216, PMID 40347270. These are historical checks, not newly credited complete-paper examinations.

Shared template wording about an amyloid-specific Deep follow-up is not credited as a case-specific run for this topic. The actual raw case records above establish provider use.

No earlier adversarial approval has been verified for this edition at the supplement date. This provenance supplement has no separate approval and is not an independent or blinded adjudication. No score or confidence change is made by this reconciliation.